Five presentations demonstrate Galapagos' commitment to inflammation and the ulcerative colitis (UC) communityNew analyses will be presented from the SELECTION data set on prediction of response and remission
Investegate announcements from Galapagos NV, Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress
SAN DIEGO, Sept. 07, 2022 Biora Therapeutics, Inc. , the biotech company that is reimagining therapeutics, announced today the appointment of Dr. Bruce Sands as board chair of its Clinical. | September 7, 2022
The Leona M. and Harry B. Helmsley Charitable Trust awarded the funds to expand its support of the Stenosis Therapy and Anti-Fibrotic Research (STAR) consortium for the development of biomarker tools for intestinal fibrosis in patients with Crohn's disease.